sglt2 inhibitors and glp-1 receptor agonists GLP1 vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Metabolic Powerhouses: GLP-1 RAs and
Description
3, 2023, Novo Nordisk filed a motion to dismiss Bjorklund's lawsuit in Louisiana federal court
An intensive discussion on the pancreatic safety of incretin-based therapies initiated by publications of a single group have led to a thorough evaluation of non-clinical and clinical data by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) (3845)
Lab Invest 94: 63-78, 2014
Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care
Mahase, Elisabeth
